News
16 September 2026
Dexa Group Molecular Pharmacologist Prof. Raymond Tjandrawinata Earns Summa Cum Laude Doctorate in Law, Proposes Equitable Pharmaceutical Patent Model
JAKARTA – Prof. Raymond Tjandrawinata, Professor of Molecular Pharmacology at Atma Jaya University and Molecular Pharmacologist at Dexa Group, has successfully completed his Doctor of Law degree at Universitas Pelita Harapan (UPH), graduating with the distinction of Summa Cum Laude His doctoral research brings together his expertise in pharmaceutical science and…
11 September 2026
PERIXA 2026 Discusses the Role of AI and Precision Medicine in Healthcare Transformation
JAKARTA — The rapid growth of Artificial Intelligence (AI) and digital technology is driving significant shifts across the healthcare ecosystem—from drug discovery and clinical practice to doctor-patient dynamics. These transformations formed the core discussion at the 2026 Dexa Periodic Scientific Meeting (PERIXA), which carried the theme “Navigating the Bio-Digital Era…
11 September 2026
Stimuno: 27 Years of Protecting the Immune System of Indonesian Families
JAKARTA – For 27 years, Stimuno has been an integral part of the health journey for Indonesian families. Since its debut in 1999, this natural immunomodulator medication has accompanied families across generations, helping maintain strong immune systems so the body is better prepared to face various health challenges. Stimuno's long…
8 September 2026
Promoting Sustainable Healthy Lifestyles, Dexa Group Offers Free Health Screenings at Wellfest 2026
SOUTH TANGERANG – A healthy lifestyle is more than a passing trend; it is an essential part of maintaining long-term quality of life. This message was at the heart of the Indonesia Wellness Festival (Wellfest) 2026, themed “The New Paradigm of Sustainable Living,” held from September 4–6, 2026, at Bintaro…
4 September 2026
Dexa Group Receives Green Economy Award for Green Pharmacy Initiative
JAKARTA – Dexa Group is strengthening Indonesia’s national pharmaceutical ecosystem by empowering 413 farmers across 34 districts in 11 provinces to supply raw materials for medicines derived from Indonesia’s biodiversity. The Green Pharmacy initiative, one of the implementations of Dexa Group’s Right to Win strategy, has once again earned the…
21 July 2026
Strengthening the Government’s Preventive Health Efforts, Sustainable Health Program Reaches More Than 16,500 People
JAKARTA – More than 16,500 people across Indonesia have participated in the Cek Kesehatan Segitiga, a free health screening program organized by Dexa Medica through Dharma Dexa since 2024. Beyond providing blood pressure, blood glucose, and cholesterol screenings, the program, now conducted at 22 locations, also integrates health education, medical…
14 July 2026
Supporting the National Health Program, Cek Segitiga Serves More Than 15,000 People
Surabaya – Through Dharma Dexa, Dexa Medica continues to implement Cek Segitiga, a free community health screening program that supports the Indonesian government’s efforts to strengthen the early detection of non-communicable diseases (NCDs). Since its launch in 2024, the program has reached more than 15,000 people through blood pressure, blood…
8 July 2026
OGB Merah at HISFARSI 2026: Reflecting Quality, Strengthening Trust
The quality of generic medicines can be demonstrated both through the production process and through the trust placed in them by healthcare professionals who use them in their practice. Building on this commitment, PT Dexa Medica presented "OGB Merah, A Reflection of Quality Generic Medicine" at the HISFARSI 2026 National…
19 June 2026
CorComm Dream Team 2026: Beyond Words, Toward Real Impact
Corporate reputation stems from consistent effort. It is built upon the ability to assess situations, deliver information transparently, maintain trust, and ensure that every message is grounded in accountability. This is the exact principle upheld by Dexa Group’s Corporate Communications department in supporting the company’s journey as a growing Indonesian…
12 June 2026
Dexa Medica Molecular Pharmacologist Prof. Raymond Tjandrawinata Ranked Among the Top 5% of Scientists Worldwide
JAKARTA — Prof. Raymond Tjandrawinata, Molecular Pharmacologist at PT Dexa Medica, has been ranked among the Top 5% of Scientists Globally by the SciRank Global Database. The recognition follows an extensive evaluation of more than 8 million researchers, 20 million scientific publications, and academic data from over 150 countries. "I…